Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters

Database
Language
Journal subject
Affiliation country
Publication year range
2.
Psychosomatics ; 48(6): 534-6, 2007.
Article in English | MEDLINE | ID: mdl-18071103

ABSTRACT

Catatonia is a disorder characterized by mutism, posturing, echophenomena, and negativism. The preferred treatment for non-malignant catatonia is benzodiazepines, which often produce a reduction in symptoms within 24 hours. Presented here is a case report of a 19-year-old woman appearing in a catatonic state that did not respond to lorazepam. On the basis of emerging evidence that atypical antipsychotics and weak N-Methyl-D-Aspartate (NMDA) receptor-antagonists may effectively treat catatonia, we treated our patient with olanzapine and amantadine, which resulted in a dramatic reduction in her catatonic symptoms.


Subject(s)
Amantadine/therapeutic use , Benzodiazepines/therapeutic use , Catatonia/drug therapy , Dopamine Agents/therapeutic use , Adult , Autistic Disorder/complications , Catatonia/diagnosis , Catatonia/etiology , Diagnosis, Differential , Drug Therapy, Combination , Female , GABA Modulators/administration & dosage , Humans , Lorazepam/administration & dosage , Olanzapine , Orientation/drug effects , Schizophrenia/complications , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL